These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34777591)

  • 1. Downregulation of amine oxidase copper containing 1 inhibits tumor progression by suppressing IL-6/JAK/STAT3 pathway activation in hepatocellular carcinoma.
    Ding Q; Lin D; Zhou Y; Li F; Lai J; Duan J; Chen J; Jiang C
    Oncol Lett; 2021 Dec; 22(6):857. PubMed ID: 34777591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AOC1 Contributes to Tumor Progression by Promoting the AKT and EMT Pathways in Gastric Cancer.
    Xu F; Xu Y; Xiong JH; Zhang JH; Wu J; Luo J; Xiong JP
    Cancer Manag Res; 2020; 12():1789-1798. PubMed ID: 32210620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased AOC1 Expression Promotes Cancer Progression in Colorectal Cancer.
    Liu F; Ou W; Tang W; Huang Z; Zhu Z; Ding W; Fu J; Zhu Y; Liu C; Xu W; Du P
    Front Oncol; 2021; 11():657210. PubMed ID: 34026633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development.
    Kirschner KM; Braun JF; Jacobi CL; Rudigier LJ; Persson AB; Scholz H
    J Biol Chem; 2014 Aug; 289(35):24452-62. PubMed ID: 25037221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y; Li W; Liu R; Guo Q; Li J; Bao Y; Zheng H; Jiang S; Hua B
    Oncol Rep; 2017 Aug; 38(2):1224-1232. PubMed ID: 28677802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CKS1B promotes the progression of hepatocellular carcinoma by activating JAK/STAT3 signal pathway.
    Liu X; Zhao D
    Anim Cells Syst (Seoul); 2021; 25(4):227-234. PubMed ID: 34408811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3.
    Tu M; He L; You Y; Li J; Yao N; Qu C; Huang W; Xu L; Luo R; Hong J
    Cell Death Dis; 2020 Oct; 11(10):830. PubMed ID: 33024090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX15 transcriptionally increases the function of AOC1 to modulate ferroptosis and progression in prostate cancer.
    Ding Y; Feng Y; Huang Z; Zhang Y; Li X; Liu R; Li H; Wang T; Ding Y; Jia Z; Yang J
    Cell Death Dis; 2022 Aug; 13(8):673. PubMed ID: 35922412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma.
    Gu FM; Li QL; Gao Q; Jiang JH; Zhu K; Huang XY; Pan JF; Yan J; Hu JH; Wang Z; Dai Z; Fan J; Zhou J
    Mol Cancer; 2011 Dec; 10():150. PubMed ID: 22171994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway.
    Gong QZ; Xiao D; Gong GY; Xu J; Wen XD; Feng F; Qu W
    Curr Cancer Drug Targets; 2019; 19(7):583-593. PubMed ID: 30585547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1.
    Wang J; Li H; Xia C; Yang X; Dai B; Tao K; Dou K
    Onco Targets Ther; 2019; 12():869-882. PubMed ID: 30774374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation.
    Kang JH; Li MJ; Luan PP; Jiang DK; Chen YW; Xu X; Yu Q; Xu YW; Su Q; Peng WH; Jian WX
    Cell Biol Int; 2020 Oct; 44(10):2053-2064. PubMed ID: 32584509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RPLP1 is highly expressed in hepatocellular carcinoma tissues and promotes proliferation, invasion and migration of human hepatocellular carcinoma Hep3b cells.
    Xie C; Cao K; Peng D; Qin L
    Exp Ther Med; 2021 Jul; 22(1):752. PubMed ID: 34035849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheum palmatum extract exerts anti-hepatocellular carcinoma effects by inhibiting signal transducer and activator of transcription 3 signaling.
    Tan ZB; Fan HJ; Wu YT; Xie LP; Bi YM; Xu HL; Chen HM; Li J; Liu B; Zhou YC
    J Ethnopharmacol; 2019 Mar; 232():62-72. PubMed ID: 30553869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.